APO Research

APO RESEARCH · REPORT

Addiction Treatment

Selected research

Market Analysis & Forecast

Global Addiction Treatment Market Analysis and Forecast 2026-2032

Market perspective

The global Addiction Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Addiction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Addiction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Addiction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Addiction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Addiction Treatment include Purdue Pharma, Pfizer, GlaxoSmithKiline, Reckitt Benckiser, Orexo, Mallinckrodt, Cipla, Allergan and Alkermes, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Addiction Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Addiction Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Addiction Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Addiction Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Addiction Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Addiction Treatment revenue, projected growth trends, production technology, application and end-user industry.

Addiction Treatment Segment by Company

Purdue Pharma

Pfizer

GlaxoSmithKiline

Reckitt Benckiser

Orexo

Mallinckrodt

Cipla

Allergan

Alkermes

Addiction Treatment Segment by Type

Tobacco/Nicotine Addiction Treatment

Tobacco/Nicotine Addiction Treatment

Alcohol Addiction Treatment

Other Substance Addiction Treatment

Addiction Treatment Segment by Application

Residential Treatment Center

Inpatient Treatment Center

Outpatient Treatment Center

Addiction Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Addiction Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Addiction Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Addiction Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Addiction Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Addiction Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Addiction Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Addiction Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tobacco/Nicotine Addiction Treatment Major Player Table 3. Tobacco/Nicotine Addiction Treatment Major Player Table 4. Alcohol Addiction Treatment Major Player Table 5. Other Substance Addiction Treatment Major Player Table 6. Global Addiction Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Residential Treatment Center Major Player Table 8. Inpatient Treatment Center Major Player Table 9. Outpatient Treatment Center Major Player Table 10. Addiction Treatment Industry Trends Table 11. Addiction Treatment Industry Drivers Table 12. Addiction Treatment Industry Opportunities and Challenges Table 13. Addiction Treatment Industry Restraints Table 14. Global Addiction Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Addiction Treatment Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Addiction Treatment Market Share by Region (2021-2026) Table 17. Global Addiction Treatment Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Addiction Treatment Market Share by Region (2027-2032) Table 19. Global Addiction Treatment Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Addiction Treatment Revenue Market Share by Players (2021-2026) Table 21. Global Addiction Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Addiction Treatment Key Players Headquarters & Area Served Table 23. Global Addiction Treatment Players, Product Type & Application Table 24. Global Addiction Treatment Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Addiction Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Addiction Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Addiction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Addiction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Addiction Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Addiction Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Addiction Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Addiction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Addiction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Addiction Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Addiction Treatment Revenue Market Share by Application (2027-2032) Table 37. Purdue Pharma Company Information Table 38. Purdue Pharma Business Overview Table 39. Purdue Pharma Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Purdue Pharma Addiction Treatment Product Portfolio Table 41. Purdue Pharma Recent Development Table 42. Pfizer Company Information Table 43. Pfizer Business Overview Table 44. Pfizer Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Pfizer Addiction Treatment Product Portfolio Table 46. Pfizer Recent Development Table 47. GlaxoSmithKiline Company Information Table 48. GlaxoSmithKiline Business Overview Table 49. GlaxoSmithKiline Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GlaxoSmithKiline Addiction Treatment Product Portfolio Table 51. GlaxoSmithKiline Recent Development Table 52. Reckitt Benckiser Company Information Table 53. Reckitt Benckiser Business Overview Table 54. Reckitt Benckiser Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Reckitt Benckiser Addiction Treatment Product Portfolio Table 56. Reckitt Benckiser Recent Development Table 57. Orexo Company Information Table 58. Orexo Business Overview Table 59. Orexo Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Orexo Addiction Treatment Product Portfolio Table 61. Orexo Recent Development Table 62. Mallinckrodt Company Information Table 63. Mallinckrodt Business Overview Table 64. Mallinckrodt Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Mallinckrodt Addiction Treatment Product Portfolio Table 66. Mallinckrodt Recent Development Table 67. Cipla Company Information Table 68. Cipla Business Overview Table 69. Cipla Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Cipla Addiction Treatment Product Portfolio Table 71. Cipla Recent Development Table 72. Allergan Company Information Table 73. Allergan Business Overview Table 74. Allergan Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Allergan Addiction Treatment Product Portfolio Table 76. Allergan Recent Development Table 77. Alkermes Company Information Table 78. Alkermes Business Overview Table 79. Alkermes Addiction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Alkermes Addiction Treatment Product Portfolio Table 81. Alkermes Recent Development Table 82. North America Addiction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Addiction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Addiction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Addiction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Addiction Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Addiction Treatment Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Addiction Treatment Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Addiction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Addiction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Addiction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Addiction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Addiction Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Addiction Treatment Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Addiction Treatment Revenue by Country (US$ Million) & (2027-2032) Table 96. China Addiction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 97. China Addiction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 98. China Addiction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 99. China Addiction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Addiction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Addiction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Addiction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Addiction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Addiction Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Addiction Treatment Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Addiction Treatment Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Addiction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Addiction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Addiction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Addiction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Addiction Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Addiction Treatment Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Addiction Treatment Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Addiction Treatment Image Figure 2. Global Addiction Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Addiction Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tobacco/Nicotine Addiction Treatment Image Figure 5. Tobacco/Nicotine Addiction Treatment Image Figure 6. Alcohol Addiction Treatment Image Figure 7. Other Substance Addiction Treatment Image Figure 8. Global Addiction Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Addiction Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 10. Residential Treatment Center Image Figure 11. Inpatient Treatment Center Image Figure 12. Outpatient Treatment Center Image Figure 13. Global Addiction Treatment Market Size (US$ Million) & (2021-2032) Figure 14. Global Addiction Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Addiction Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Addiction Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Addiction Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Addiction Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Addiction Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Addiction Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Addiction Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Addiction Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Addiction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Addiction Treatment Revenue Share by Type (2021-2032) Figure 26. North America Addiction Treatment Revenue Share by Application (2021-2032) Figure 27. North America Addiction Treatment Revenue Share by Country (2021-2032) Figure 28. United States Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Addiction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Addiction Treatment Revenue Share by Type (2021-2032) Figure 33. Europe Addiction Treatment Revenue Share by Application (2021-2032) Figure 34. Europe Addiction Treatment Revenue Share by Country (2021-2032) Figure 35. Germany Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Addiction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Addiction Treatment Revenue Share by Type (2021-2032) Figure 45. China Addiction Treatment Revenue Share by Application (2021-2032) Figure 46. Asia Addiction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Addiction Treatment Revenue Share by Type (2021-2032) Figure 48. Asia Addiction Treatment Revenue Share by Application (2021-2032) Figure 49. Asia Addiction Treatment Revenue Share by Region (2021-2032) Figure 50. Japan Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Addiction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Addiction Treatment Revenue Share by Type (2021-2032) Figure 58. SAMEA Addiction Treatment Revenue Share by Application (2021-2032) Figure 59. SAMEA Addiction Treatment Revenue Share by Country (2021-2032) Figure 60. Brazil Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Addiction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tobacco/Nicotine Addiction Treatment
  • Tobacco/Nicotine Addiction Treatment
  • Alcohol Addiction Treatment
  • Other Substance Addiction Treatment
Applications
  • Residential Treatment Center
  • Inpatient Treatment Center
  • Outpatient Treatment Center
Companies covered
  • Purdue Pharma
  • Pfizer
  • GlaxoSmithKiline
  • Reckitt Benckiser
  • Orexo
  • Mallinckrodt
  • Cipla
  • Allergan
  • Alkermes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Addiction Treatment Market by Type
  3. 1.2.1 Global Addiction Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tobacco/Nicotine Addiction Treatment
  5. 1.2.3 Tobacco/Nicotine Addiction Treatment
  6. 1.2.4 Alcohol Addiction Treatment
  7. 1.2.5 Other Substance Addiction Treatment
  8. 1.3 Addiction Treatment Market by Application
  9. 1.3.1 Global Addiction Treatment Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Residential Treatment Center
  11. 1.3.3 Inpatient Treatment Center
  12. 1.3.4 Outpatient Treatment Center
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Addiction Treatment Market Dynamics
  1. 2.1 Addiction Treatment Industry Trends
  2. 2.2 Addiction Treatment Industry Drivers
  3. 2.3 Addiction Treatment Industry Opportunities and Challenges
  4. 2.4 Addiction Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Addiction Treatment Market Perspective (2021-2032)
  2. 3.2 Global Addiction Treatment Growth Trends by Region
  3. 3.2.1 Global Addiction Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Addiction Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Addiction Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Addiction Treatment Revenue by Players
  2. 4.1.1 Global Addiction Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Addiction Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Addiction Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Addiction Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Addiction Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Addiction Treatment Players, Product Type & Application
  8. 4.5 Global Addiction Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Addiction Treatment Market CR5 and HHI
  11. 4.6.3 2025 Addiction Treatment Tier 1, Tier 2, and Tier 3
5 Addiction Treatment Market Size by Type
  1. 5.1 Global Addiction Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Addiction Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Addiction Treatment Revenue Market Share by Type (2021-2032)
6 Addiction Treatment Market Size by Application
  1. 6.1 Global Addiction Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Addiction Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Addiction Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Purdue Pharma
  2. 7.1.1 Purdue Pharma Company Information
  3. 7.1.2 Purdue Pharma Business Overview
  4. 7.1.3 Purdue Pharma Addiction Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Purdue Pharma Addiction Treatment Product Portfolio
  6. 7.1.5 Purdue Pharma Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Addiction Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Addiction Treatment Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 GlaxoSmithKiline
  14. 7.3.1 GlaxoSmithKiline Company Information
  15. 7.3.2 GlaxoSmithKiline Business Overview
  16. 7.3.3 GlaxoSmithKiline Addiction Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKiline Addiction Treatment Product Portfolio
  18. 7.3.5 GlaxoSmithKiline Recent Developments
  19. 7.4 Reckitt Benckiser
  20. 7.4.1 Reckitt Benckiser Company Information
  21. 7.4.2 Reckitt Benckiser Business Overview
  22. 7.4.3 Reckitt Benckiser Addiction Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Reckitt Benckiser Addiction Treatment Product Portfolio
  24. 7.4.5 Reckitt Benckiser Recent Developments
  25. 7.5 Orexo
  26. 7.5.1 Orexo Company Information
  27. 7.5.2 Orexo Business Overview
  28. 7.5.3 Orexo Addiction Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Orexo Addiction Treatment Product Portfolio
  30. 7.5.5 Orexo Recent Developments
  31. 7.6 Mallinckrodt
  32. 7.6.1 Mallinckrodt Company Information
  33. 7.6.2 Mallinckrodt Business Overview
  34. 7.6.3 Mallinckrodt Addiction Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Mallinckrodt Addiction Treatment Product Portfolio
  36. 7.6.5 Mallinckrodt Recent Developments
  37. 7.7 Cipla
  38. 7.7.1 Cipla Company Information
  39. 7.7.2 Cipla Business Overview
  40. 7.7.3 Cipla Addiction Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cipla Addiction Treatment Product Portfolio
  42. 7.7.5 Cipla Recent Developments
  43. 7.8 Allergan
  44. 7.8.1 Allergan Company Information
  45. 7.8.2 Allergan Business Overview
  46. 7.8.3 Allergan Addiction Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Allergan Addiction Treatment Product Portfolio
  48. 7.8.5 Allergan Recent Developments
  49. 7.9 Alkermes
  50. 7.9.1 Alkermes Company Information
  51. 7.9.2 Alkermes Business Overview
  52. 7.9.3 Alkermes Addiction Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Alkermes Addiction Treatment Product Portfolio
  54. 7.9.5 Alkermes Recent Developments
8 North America
  1. 8.1 North America Addiction Treatment Revenue (2021-2032)
  2. 8.2 North America Addiction Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Addiction Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Addiction Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Addiction Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Addiction Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Addiction Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Addiction Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Addiction Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Addiction Treatment Revenue by Country
  11. 8.6.1 North America Addiction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Addiction Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Addiction Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Addiction Treatment Revenue (2021-2032)
  2. 9.2 Europe Addiction Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Addiction Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Addiction Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Addiction Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Addiction Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Addiction Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Addiction Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Addiction Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Addiction Treatment Revenue by Country
  11. 9.6.1 Europe Addiction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Addiction Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Addiction Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Addiction Treatment Revenue (2021-2032)
  2. 10.2 China Addiction Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Addiction Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Addiction Treatment Revenue by Type (2027-2032)
  5. 10.3 China Addiction Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Addiction Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Addiction Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Addiction Treatment Revenue by Application (2027-2032)
  9. 10.5 China Addiction Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Addiction Treatment Revenue (2021-2032)
  2. 11.2 Asia Addiction Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Addiction Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Addiction Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Addiction Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Addiction Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Addiction Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Addiction Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Addiction Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Addiction Treatment Revenue by Country
  11. 11.6.1 Asia Addiction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Addiction Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Addiction Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Addiction Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Addiction Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Addiction Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Addiction Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Addiction Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Addiction Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Addiction Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Addiction Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Addiction Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Addiction Treatment Revenue by Country
  11. 12.6.1 SAMEA Addiction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Addiction Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Addiction Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research